RPS6KB1 and cancer: In addition, Komatsu et al. found that S6K could change the sensitivity of KRAS-mutant cancer cells to ERK inhibitors [53], and our results demonstrate that S6K cooperates with PD-L1 to induce the up-regulation of S6K.